Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

NCT02660840 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study in Healthy Subjects

Interventions

DRUG: 0.5 mg Flupentixol film-coated tablet (test treatment)
DRUG: 1 mg Flupentixol film-coated tablet (test treatment)
DRUG: 5 mg Flupentixol film-coated tablet (test treatment)
DRUG: 0.5 mg Flupentixol coated tablet (reference treatment)
DRUG: 1 mg Flupentixol coated tablet (reference treatment)
DRUG: 5 mg Flupentixol coated tablet (reference treatment)

Sponsor

H. Lundbeck A/S